Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Ling

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Addiction (Abingdon, England)|May 12, 2007
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacityAhmed Elkashef, Richard A Rawson, Edwina Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 25, 2013
An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-AmericansRichard C Crist, Toni-Kim Clarke, Alfonso Ang, et al.
Addiction (Abingdon, England)|July 27, 2005
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkWalter Ling, Leslie Amass, Steve Shoptaw, et al.
Journal of Substance Abuse Treatment|March 24, 2010
From research to the real world: buprenorphine in the decade of the Clinical Trials NetworkWalter Ling, Petra Jacobs, Maureen Hillhouse, et al.
Addiction (Abingdon, England)|April 1, 2008
Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST)Rachel Humeniuk, Robert Ali, Thomas F Babor, et al.
Journal of Psychoactive Drugs|November 4, 2014
Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) studyCheryl Teruya, Robert P Schwartz, Shannon Gwin Mitchell, et al.
BMC Health Services Research|June 14, 2017
Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocolYurong Mao, Zunyou Wu, Jennifer M McGoogan, et al.
Addiction (Abingdon, England)|November 25, 2015
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trialYih-Ing Hser, Elizabeth Evans, David Huang, et al.
Plos One|October 22, 2016
Loss to Follow-Up from HIV Screening to ART Initiation in Rural ChinaDiane Gu, Yurong Mao, Zhenzhu Tang, et al.
Biological Psychiatry|August 13, 2005
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusersEdythe D London, Steven M Berman, Bradley Voytek, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Addiction (Abingdon, England)|May 12, 2007
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacityAhmed Elkashef, Richard A Rawson, Edwina Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 25, 2013
An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-AmericansRichard C Crist, Toni-Kim Clarke, Alfonso Ang, et al.
Addiction (Abingdon, England)|July 27, 2005
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkWalter Ling, Leslie Amass, Steve Shoptaw, et al.
Journal of Substance Abuse Treatment|March 24, 2010
From research to the real world: buprenorphine in the decade of the Clinical Trials NetworkWalter Ling, Petra Jacobs, Maureen Hillhouse, et al.
Addiction (Abingdon, England)|April 1, 2008
Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST)Rachel Humeniuk, Robert Ali, Thomas F Babor, et al.
Journal of Psychoactive Drugs|November 4, 2014
Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) studyCheryl Teruya, Robert P Schwartz, Shannon Gwin Mitchell, et al.
BMC Health Services Research|June 14, 2017
Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocolYurong Mao, Zunyou Wu, Jennifer M McGoogan, et al.
Addiction (Abingdon, England)|November 25, 2015
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trialYih-Ing Hser, Elizabeth Evans, David Huang, et al.
Plos One|October 22, 2016
Loss to Follow-Up from HIV Screening to ART Initiation in Rural ChinaDiane Gu, Yurong Mao, Zhenzhu Tang, et al.
Biological Psychiatry|August 13, 2005
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusersEdythe D London, Steven M Berman, Bradley Voytek, et al.
Pageof 17